108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
DNA NUCLEASE GUIDED TRANSPOSASE COMPOSITIONS AND METHODS OF USE THEREOF
#1802METHOD OF PROVIDING BROAD-SPECTRUM RESISTANCE TO PLANTS, AND PLANTS THUS OBTAINED
#1803COMPOSITIONS AND METHODS FOR TRANSFORMATION OF EMBRYO EXPLANT POPULATIONS
#1804COMPOSITIONS AND METHODS FOR CLL1 MODIFICATION
#1805ANTIFIBROTIC AND ANTITUMOR ACTIVITY OF CD63 BLOCKADE
#1806GENOMIC EDITING OF COMPLEMENT
#1807SYSTEMS AND METHODS FOR TREATING ALPHA 1-ANTITRYPSIN (A1AT) DEFICIENCY
#1808Application of prokaryotic Argonaute protein with only RNA target cleavage activity in RNA editing
#1809PHOSPHOROTHIOATE NUCLEIC ACID CONJUGATES INCLUDING DNA EDITING ENZYMES
#1810COMPOSITION AND METHOD FOR HIGH-MULTIPLEXED GENOME ENGINEERING USING SYNTHETIC CRISPR ARRAYS
#1811ENZYMES WITH RUVC DOMAINS
#1812EDITING OF CCR5 RECEPTOR GENE TO PROTECT AGAINST HIV INFECTION
#1813NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS
#1814Delivery of therapeutics in vivo via a CRISPR-based cascade system
#1815CRISPR-ASSOCIATED BASED-EDITING OF THE COMPLEMENTARY STRAND
#1816Methods and products for genetic engineering
#1817ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES
#1818RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1
#1819MODULATION OF A PATHOGENIC PHENOTYPE IN TH1 CELLS
#1820DOWN-REGULATION OF ENDOGENOUS GENES
#1821CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS FOR VIRUS DETECTION
#1822SILICA-BASED CHROMATOGRAPHIC PROCESSES FOR ISOLATING NUCLEIC ACID-PROTEIN COMPLEXES AND DETECTING TARGET NUCLEIC ACIDS
#1823COMPOSITIONS AND METHODS FOR DETECTION OF A NUCLEIC ACID
#1824FUNGAL STRAINS COMPRISING ENHANCED PROTEIN PRODUCTIVITY PHENOTYPES AND METHODS THEREOF
#1825Method for Producing Genetically Engineered Cells
#1826PNMA2-BASED CAPSIDS AND USES THEREOF
#1827OLEIC ACID -ENRICHED PLANT BODY HAVING GENETICALLY MODIFIED FAD2 AND PRODUCTION METHOD THEREOF
#1828CANNABIS PLANT WITH INCREASED CANNABIGEROLIC ACID
#1829CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#1830TWO-PLASMID SYSTEM FOR PRIME EDITING IN YEAST, USE THEREOF, AND METHOD FOR PRIME EDITING IN YEAST
#1831GENE EDITING SYSTEMS COMPRISING A CRISPR NUCLEASE AND USES THEREOF
#1832COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFICIENCY GENE DISRUPTION
#1833ENHANCING EFFICIENCY OF TARGETED GENE KNOCKIN BY BASE EDITORS
#1834CRISPR DNA TARGETING ENZYMES AND SYSTEMS
#1835NUCLEASE-MEDIATED GENOME EDITING
#1836TEMPERATURE-SENSITIVE CAS9 PROTEIN
#1837POLYPEPTIDE FUSIONS OR CONJUGATES FOR GENE EDITING
#1838ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE
#1839ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE
#1840COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1
#1841PROGRAMMABLE RNA EDITING PLATFORM
#1842Paraoxonase fusion polypeptides and related compositions and methods
#1843Genetically modified organisms for producing psychotropic alkaloids
#1844COMPOSITIONS AND METHODS FOR GENE EDITING WITH WOOLLY MAMMOTH ALLELES
#1845Synthetic system for tunable thresholding of protein signals
#1846Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
#1847PROGRAMMABLE RNA WRITING USING CRISPR EFFECTORS AND TRANS-SPLICING TEMPLATES
#1848REGULATORY SYSTEM FOR EXPRESSION OF A GENE OF INTEREST IN A TARGET CELL AND METHOD OF USE THEREOF
#1849COMPOSITIONS AND METHODS FOR THE TARGETING OF PTBP1
#1850METHODS OF PRECISE GENOME EDITING BY IN SITU CUT AND PASTE (ICAP)
#1851METHOD FOR PRODUCING TEMPERATURE-SENSITIVE MALE STERILE PLANT
#1852CAS-READY MOUSE EMBRYONIC STEM CELLS AND MICE AND USES THEREOF
#1853GENETICALLY ENGINEERED STRAIN OF ZYMOMONAS MOBILIS AND USES THEREOF
#1854METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELL BY USING CRISPR/CAS SYSTEM
#1855GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS
#1856CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING
#1857GENE FUNCTION CONTROL BY NOVEL GUIDE NUCLEIC ACID MECHANISM
#1858Class II, type V CRISPR systems
#1859COMPOSITIONS COMPRISING A NUCLEASE AND USES THEREOF
#1860BIOCONTAINMENT/BIOCONTROL SYSTEM AND METHODS
#1861Methods and compositions for generating complex trait loci
#1862DE NOVO ENGINEERING OF A BACTERIAL LIFESTYLE PROGRAM
#1863NON-TOXIC CAS9 ENZYME AND APPLICATION THEREOF
#1864DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS
#1865ENGINEERED NUCLEIC ACIDS TARGETING LONG NONCODING RNA INVOLVED IN PATHOGENIC INFECTION
#1866CFTR-modulating compositions and methods
#1867Circular RNAS and preparation methods thereof
#1868SYNTHETIC TRANSCRIPTION FACTORS
#1869TRANSCRIPTIONAL PRODUCT IN CELLS OF ORGANISM INCLUDING HUMAN, TRANSFECTED RNA, AND TOOL FOR PURIFYING COMPLEX THEREOF
#1870ECTOPIC CELLULAR GROWTH FACTOR EXPRESSION FOR LOW-COST PRODUCTION OF CELL-CULTURED FOODS
#1871Polypeptide variants
#1872ABCA4 TRANS-SPLICING MOLECULES
#1873COMPOSITIONS AND METHODS FOR UPREGULATING ISOFORMS OF DYSTROPHIN AS THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY (DMD)
#1874Compositions and methods of treating ocular diseases
#1875COMPOUNDS AND METHODS FOR BIOFILM DISRUPTION AND PREVENTION
#1876IMMUNE CELL FUNCTION
#1877GENETIC ENGINEERING OF MACROPHAGES FOR IMMUNOTHERAPY
#1878HYPERPROLACTINEMIA OR LACTATION WITHOUT PREGNANCY
#1879METHODS AND COMPOSITIONS FOR IMPROVING YIELD CHARACTERISTICS IN PLANTS
#1880MULTI-CHAMBER DEVICE FOR DETECTING PATHOGENS/MOLECULES AND METHODS OF USING SAME
#1881HIGH-PLEX GUIDE POOLING FOR NUCLEIC ACID DETECTION
#1882Crispr enzymes and systems
#1883CHIMERIC PROTEINS AND METHODS OF REGULATING GENE EXPRESSION
#1884SERPINA-MODULATING COMPOSITIONS AND METHODS
#1885Methods and compositions for modulating a genome
#1886REPROGRAMMABLE TNPB POLYPEPTIDES AND USE THEREOF
#1887Methods and Systems for Guide RNA Design and Use
#1888COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#1889COMPOSITIONS AND METHODS FOR ALTERING STEM LENGTH IN SOLANACEAE
#1890METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR
#1891HIV Pseudovirus Particles and Method for Preparing the Same
#1892METHODS AND COMPOSITIONS FOR INDUCING TUMOR CELL DEATH
#1893CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
#1894METHOD FOR PRODUCING TARGET DNA SEQUENCE AND CLONING VECTOR
#1895ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES
#1896COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES FOR INDUCING CELL DEATH
#1897GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE
#1898GENE THERAPY FOR TREATMENT OF INFERTILITY
#1899PAH-MODULATING COMPOSITIONS AND METHODS
#1900RETROVIRAL VECTORS
#1901METHOD OF PREPARING ANTIBODY CARRYING A UNIVERSAL SITE-DIRECTED COUPLING INTERFACE BASED ON GENETICALLY MODIFIED VERTEBRATE
#1902SYSTEM, METHOD, COMPUTER-ACCESSIBLE MEDIUM AND APPARATUS FOR DNA MAPPING
#1903CRISPNA FOR GENOME EDITING
#1904COMPOSITIONS AND METHODS FOR INSTANT NUCLEIC ACID DETECTION
#1905Methods and compositions for modulating a genome
#1906METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING
#1907INIR19 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONS
#1908INHT20 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONS
#1909COMPOSITIONS AND METHODS FOR EPIGENETIC EDITING
#1910Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
#1911GENE CORRECTION OF POMPE DISEASE AND OTHER AUTOSOMAL RECESSIVE DISORDERS VIA RNA-GUIDED NUCLEASES
#1912HIGH DEFINITION MOLECULAR ARRAY FEATURE GENERATION USING PHOTORESIST
#1913Adenosine nucleobase editors and uses thereof
#1914SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING
#1915VARIANTS OF CAS12A NUCLEASES AND METHODS OF MAKING AND USE THEREOF
#1916VARIANTS OF CAS12A NUCLEASES AND METHODS OF MAKING AND USE THEREOF
#1917Methods and compositions for modulating a genome
#1918TRANSPOSASE-MEDIATED IMAGING OF THE ACCESSIBLE GENOME
#1919Polynucleotides, Compositions, and Methods for Genome Editing
#1920METHOD OF GENE DELIVERY TO RETINAL ASTROCYTES
#1921METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS
#1922IN UTERO CRISPR-MEDIATED THERAPEUTIC EDITING OF GENES
#1923METHOD OF MODIFYING GENOMIC DNA AND METHOD OF DETECTING MODIFICATION
#1924HUMAN HEMATOPOIETIC STEM CELL HAVING A MODIFIED BCL11A GENE AND METHODS OF MAKING THE CELL
#1925SYSTEMS AND METHODS FOR REGULATING GENE EXPRESSION OR ACTIVITY
#1926Guide RNA Designs and Complexes for Tracr-less Type V Cas Systems
#1927RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS
#1928Compositions, systems, and methods for regulation of hepatitis B virus through targeted gene repression
#1929Compositions, systems, and methods for regulation of hepatitis b virus through targeted gene repression
#1930Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
#1931ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF
#1932METHOD FOR PRODUCING GENETICALLY MODIFIED CELLS
#1933Polypeptides
#1934METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
#1935ALTERING THE NORMAL BALANCE OF MICROBIAL POPULATIONS
#1936MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS
#1937GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES
#1938PROTOPARVOVIRUS AND TETRAPARVOVIRUS COMPOSITIONS AND METHODS FOR GENE THERAPY
#1939COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TGFßRII ENGINEERED T CELL THERAPY
#1940METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D
#1941GENETICALLY MODIFIED INDUCED PLURIPOTENT STEM CELLS AND METHODS OF USE THEREOF
#1942VECTOR-FREE PROCESS FOR MANUFACTURE OF ENGINEERED IMMUNE CELLS
#1943Guide RNA Designs and Complexes for Type V Cas Systems
#1944INIR11 TRANSGENIC MAIZE WITH JUNCTION SEQUENCE DELETIONS
#1945DNASE VARIANTS
#1946Antibody-evading virus vectors
#1947SYSTEMS AND METHODS FOR GENOME-WIDE ANNOTATION OF GENE REGULATORY ELEMENTS LINKED TO CELL FITNESS
#1948SELECTIVE PROTECTION OF NUCLEIC ACIDS
#1949ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
#1950ALLELE-SPECIFIC GENOME EDITING OF THE NR2E3 MUTATION G56R
#1951PROGRAMMABLE TRANSPOSASES AND USES THEREOF
#1952MODULATING CELLULAR REPAIR MECHANISMS FOR GENOMIC EDITING
#1953METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME
#1954COMPOSITIONS AND METHODS TO INCREASE RESISTANCE TO PHYTOPHTHORA SOJAE IN SOYBEAN
#1955TRANSGENIC PLANT WITH REDUCED HEAVY METALS AND METHODS FOR PREPARATION THEREOF
#1956MULTIPLEX TARGETED RECOMBINATIONS FOR TRAIT INTROGRESSION APPLICATIONS
#1957Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells
#1958COMPOSITIONS AND METHODS TO TREAT CANCER
#1959Polypeptides
#1960Compositions, systems, and methods for epigenetic regulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) gene expression
#1961METHOD FOR PRODUCING REGENERATED T CELL VIA IPS CELL
#1962TARGETING CAP-DEPENDENT TRANSLATION TO REDUCE SEIZURES IN MTOR DISORDERS
#1963METHODS FOR TARGETED PROTEIN DEGRADATION
#1964Method Of Using A Plungerless Aspiration And/Or Injection Device
#1965TREATMENT OF NEUROLOGICAL DISEASES
#1966COMBINATION OF DEOXYRIBONUCLEASE ENZYME AND CELL THERAPIES FOR TREATMENT OF CANCER
#1967COMPOSITIONS AND METHODS FOR GENETIC MANIPULATION OF METHANOTROPHS
#1968A PLASMID FOR TRANSFORMATION, A METHOD FOR PRODUCING A TRANSFORMANT USING THE SAME AND A METHOD OF TRANSFORMATION
#1969METHODS AND COMPOSITIONS FOR IMPROVING YIELD TRAITS
#1970Phage-derived particles for in situ delivery of DNA payload into population
#1971DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING
#1972NON-TOXIC CAS9 ENZYME AND APPLICATION THEREOF
#1973RESCUE STRATEGIES FOR BEST1 LOSS- AND GAIN-OF-FUNCTION MUTATIONS
#1974MULTIPLEX EPIGENOME EDITING
#1975T-DNA MEDIATED GENETIC MODIFICATION
#1976ENZYME VARIANTS
#1977MODIFIED CAS9 SYSTEM HAVING A DOMINANT NEGATIVE EFFECTOR ON NON-HOMOLOGOUS END-JOINING FUSED THERETO AND ITS USE FOR IMPROVED GENE EDITING
#1978Engineered Cells for Increased Collagen Production
#1979ABCA4 TRANS-SPLICING MOLECULES
#1980DELIVERY OF MOLECULES TO CELLS USING TROGOCYTOSIS AND ENGINEERED CELLS
#1981BIALLELIC KNOCKOUT OF B2M
#1982APPLICATION OF CRISPR/CAS13 FOR THERAPY OF RNA VIRUS AND/OR BACTERIUM INDUCED DISEASES
#1983COMPOSITIONS AND METHODS FOR CD5 MODIFICATION
#1984COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS USING CRISPR-BASED BASE EDITOR SYSTEMS
#1985LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY
#1986GENERATION OF SURROGATE SIRES AND DAMS BY ABLATION OF ENDOGENOUS GERMLINE
#1987Methods and compositions for modulating a genome
#1988DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTIC APPLICATIONS
#1989PLANT REGULATORY ELEMENTS AND USES THEREOF FOR AUTOEXCISION
#1990CUTIBACTERIUM ACNES RECOMBINANT PHAGES, METHOD OF PRODUCTION AND USES THEREOF
#1991Targeted trans-splicing using CRISPR/Cas13
#1992SIGNAL BOOST CASCADE ASSAY
#1993CIRCULAR RNA
#1994CYTOSINE TO GUANINE BASE EDITOR
#1995OPTIMIZED ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME
#1996COMPOSITIONS COMPRISING A VARIANT POLYPEPTIDE AND USES THEREOF
#1997Engineered nucleases, compositions, and methods of use thereof
#1998GENOMIC EDITING WITH SITE-SPECIFIC RETROTRANSPOSONS
#1999Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems
#2000CRYSTAL STRUCTURE OF CRISPR CPF1
#2001ENZYMES AND ENZYME COMPOSITIONS FOR CLEANING
#2002Brassica plants with increased locules
#2003AAV VECTORS FOR GENE EDITING
#2004LIPID COMPOSITION FOR THE DELIVERY OF THERAPEUTIC CARGOS
#2005COMPOSITIONS AND METHODS FOR CD7 MODIFICATION
#2006COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF
#2007METHOD FOR PRODUCING BIRD PRODUCING HUMAN IMMUNOGLOBULIN FC AND TARGET PROTEIN
#2008Compositions of matter for detection assays
#2009REAGENT AND METHOD FOR DETECTING TARGET NUCLEIC ACID USING SAME
#2010COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A
#2011ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS
#2012RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
#2013UNIVERSAL RIBOSWITCH FOR INDUCIBLE GENE EXPRESSION
#2014Small type II-D Cas proteins and methods of use thereof
#2015SPLIT PRIME EDITING PLATFORMS
#2016METHODS AND COMPOSITIONS FOR NUCLEIC ACID AND PROTEIN PAYLOAD DELIVERY
#2017USE OF ENHANCED POL THETA ACTIVITY FOR EUKARYOTIC GENOME ENGINEERING
#2018Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells
#2019TARGETED GENE REGULATION OF HUMAN IMMUNE CELLS WITH CRISPR-CAS SYSTEMS
#2020COMPOSITIONS COMPRISING AN RNA GUIDE TARGETING TRAC AND USES THEREOF
#2021NUCLEIC ACID CONSTRUCTS COMPRISING GENE EDITING MULTI-SITES
#2022INHIBITION OF UNINTENDED MUTATIONS IN GENE EDITING
#2023Methods and compositions for modulating a genome
#2024COMPOSITIONS AND METHODS FOR MODIFYING RNA
#2025NOVEL NUCLEIC ACID-GUIDED NUCLEASES
#2026CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#2027MATERIALS AND METHODS FOR MODIFYING EXPRESSION OF MYOSIN HEAVY CHAIN GENES
#2028Angiogenin expression in plants
#2029ENGINEERED IMMUNE CELLS FOR REAGENT DELIVERY
#2030HIGH SEQUENCE FIDELITY NUCLEIC ACID SYNTHESIS AND ASSEMBLY
#2031Compositions and Methods for Reducing HLA-A in a Cell
#2032Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
#2033COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND/OR NEUROREGENERATION
#2034ONE-LOCUS INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE OR TEMPERATURE-INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE
#2035DETERMINATION OF BASE MODIFICATIONS OF NUCLEIC ACIDS
#2036METHODS AND COMPOSITIONS FOR MODULATING A GENOME
#2037ADENINE BASE EDITOR HAVING INCREASED THYMINE-CYTOSINE SEQUENCE-SPECIFIC CYTOSINE EDITING ACTIVITY, AND USE THEREOF
#2038CO-PACKAGING TO MITIGATE INTERMOLECULAR RECOMBINATION
#2039TARGETING MICRORNA TO REGULATE NATIVE GENE FUNCTION BY GENOME EDITING
#2040INIR4 TRANSGENIC MAIZE
#2041INIR17 TRANSGENIC MAIZE
#2042CAS9 VARIANTS AND METHODS OF USE
#2043Compositions and Methods for Kallikrein (KLKB1) Gene Editing
#2044Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
#2045NOVEL CAS13B ORTHOLOGUES CRISPR ENZYMES AND SYSTEMS
#2046KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION
#2047PRIME EDITING USING HIV REVERSE TRANSCRIPTASE AND CAS9 OR VARIANT THEREOF
#2048Engineered red blood cells having rare antigen phenotypes
#2049TARGETED-ANTIBACTERIAL-PLASMIDS COMBINING CONJUGATION AND CRISPR/CAS SYSTEMS AND USES THEREOF
#2050ENGINEERED NK CELLS
#2051Non-human animals comprising a humanized coagulation factor 12 locus
#2052Systems for nucleic acid-based data storage
#2053METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS
#2054PRODUCTION CELLS
#2055PRECISE GENOME DELETION AND REPLACEMENT METHOD BASED ON PRIME EDITING
#2056CONSTRUCTS AND USES THEREOF FOR EFFICIENT AND SPECIFIC GENOME EDITING
#2057Method of early diagnosis and composition of gRNA for treating mental health diseases using genome editing and cell and gene therapy
#2058Genome editing method
#2059EXCISABLE PLANT TRANSGENIC LOCI WITH SIGNATURE PROTOSPACER ADJACENT MOTIFS OR SIGNATURE GUIDE RNA RECOGNITION SITES
#2060MEDIATORS OF GENE SILENCING
#2061COMPOSITIONS COMPRISING A NUCLEASE AND USES THEREOF
#2062TREATMENTS FOR RETINAL DEGENERATIVE DISEASES
#2063HYBRIDIZED GUIDE NUCLEIC ACIDS FOR USE WITH TEMPLATE-BASED GENE EDITORS
#2064GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC GRANULOMATOUS DISEASE
#2065METHODS AND MEANS OF INACTIVATING RNA BASED VACCINES
#2066NOVEL CRISPR-CAS12F SYSTEMS AND USES THEREOF
#2067COMPOSITIONS COMPRISING A VARIANT CRISPR NUCLEASE POLYPEPTIDE AND USES THEREOF
#2068ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE TRANSTHYRETIN GENE
#2069DAUGHTERLESS MALE MAMMALS FOR NON-HUMAN POPULATION SUPPRESSION
#2070MATERIALS AND METHODS FOR BIOENGINEERED IPSC POPULATIONS
#2071GENETICALLY MODIFIED PRIMARY CELLS FOR ALLOGENEIC CELL THERAPY
#2072METHODS FOR ENHANCING THERAPEUTIC EFFICACY OF ISOLATED CELLS FOR CELL THERAPY
#2073HPV therapeutic nucleic acid vaccine
#2074CRUCIAN CARP (CARASSIUS AURATUS) STRAIN WITHOUT INTERMUSCULAR BONES AND BREEDING METHOD THEREOF
#2075JAK3 GENE-MUTATED, SEVERE COMBINED IMMUNODEFICIENCY ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR
#2076SENSITIVE QUANTITATIVE DETECTION OF SARS-CoV-2 USING DIGITAL WARM-START CRISPR ASSAY
#2077RNA and DNA analysis using engineered surfaces
#2078Methods and compositions for modulating a genome
#2079PLASMID FOR TRANSFORMATION, METHOD FOR PRODUCING TRANSFORMANT USING THE SAME, AND TRANSFORMATION METHOD
#2080Controllable Transcription
#2081Universal platform to enhance CRISPR-based gene editing for in vivo therapies
#2082METHODS AND COMPOSITIONS FOR CONTROLLING MERISTEM SIZE FOR CROP IMPROVEMENT
#2083INSECT RESISTANT INIR6 TRANSGENIC MAIZE PLANTS LACKING A SELECTABLE MARKER AND JUNCTION
#2084MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES
#2085CRISPR SAM BIOSENSOR CELL LINES AND METHODS OF USE THEREOF
#2086GENETIC TOOL FOR THE TRANSFORMATION OF CLOSTRIDIUM BACTERIA
#2087ADENINE BASE EDITOR LACKING CYTOSINE EDITING ACTIVITY AND USE THEREOF
#2088Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
#2089Methods and compositions for modulating a genome
#2090Optimized protein linkers and methods of use
#2091Polynucleotides, Compositions, and Methods for Genome Editing Involving Deamination
#2092MAMMALIAN MOBILE ELEMENT COMPOSITIONS, SYSTEMS AND THERAPEUTIC APPLICATIONS
#2093METHOD FOR THE ASSEMBLY OF LARGE NUCLEIC ACIDS FROM SHORT FRAGMENTS
#2094RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING CAG REPEAT DISEASES
#2095DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF LRRK2
#2096ADOPTIVE CELL THERAPY FOR TREATMENT OF CANCER ASSOCIATED WITH LOSS OF HETEROZYGOSITY
#2097OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
#2098INFLUENZA A-RESISTANT ANIMALS HAVING EDITED ANP32 GENES
#2099DIGITAL CRISPR-BASED METHOD FOR THE RAPID DETECTION AND ABSOLUTE QUANTIFICATION OF NUCLEIC ACIDS
#2100RNA and DNA analysis using engineered surfaces